Search results

Icon explanation

close

Abstract

ePoster

Handout

Image

Journal Article

Presentation

Video

Webcast

41. Outer Membrane Permeabilizer

    Aileen Rubio, Cambridge, United States

    06 September 2017

    Relevance:

     

    55%

     

    

    Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Boston, United States
    Conference lecture

    Bacterial Susceptibility & Resistance

42. Finding New Therapeutic Agents: Triumphs and Tragedies

    Heinz Moser, San Francisco, United States

    06 September 2017

    Relevance:

     

    55%

     

    

    Event: ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Boston, United States
    Conference lecture

    Bacterial Susceptibility & Resistance

43. FDA

    Ed Cox, Silver Spring, MD, United States

    21 September 2016

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

44. EMA

    Marco Cavaleri, London, United Kingdom

    21 September 2016

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

45. Current tools and approaches for setting breakpoints

    Johan Mouton, Rotterdam, The Netherlands

    21 September 2016

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

46. Global harmonization of breakpoints – can it be achieved?

    Gunnar Kahlmeter, Växjö, Sweden

    21 September 2016

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

47. MIC wild type distributions and ECOFFs and their role in setting clinical breakpoints

    John Turnidge, Sydney, Australia

    21 September 2016

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

48. Approaches for defining safe and effective regimens for children

    Mike Sharland, London, United Kingdom

    21 September 2016

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

49. Overview of the current efforts

    Herman Goossens, Edegem, Belgium

    21 September 2016

    Relevance:

     

    55%

     

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance

50. Regulatory issues around test development and validation

    Ron Jones, North Liberty, IA, United States

    21 September 2016

    Relevance:

     

    50%

     

    No material available

    

    Event: ESCMID/ASM Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance
    Vienna, Austria
    Conference lecture

    Bacterial Susceptibility & Resistance